| |
| |
|
| Insider
Information: |
Devinney Erick Wayne |
| Relationship: |
Chief Innovation Officer |
| City: |
Alachua |
| State: |
FL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
177,474 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,212,147 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
177,474 |
|
|
| Total
Value |
$1,212,147 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -18.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Axogen Inc |
AXGN |
Chief Innovation Officer |
2024-03-21 |
177,474 |
2017-03-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
42 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AXGN |
Axogen Inc |
VP, Clinical&Translational Sc |
• – – |
2017-03-14 |
4 |
OE |
$0.27 |
$1,355 |
D/D |
5,018 |
5,018 |
0 |
- |
|
| AXGN |
Axogen Inc |
VP, Clinical&Translational Sc |
• – – |
2019-02-15 |
4 |
D |
$17.57 |
$26,320 |
D/D |
(1,498) |
41,971 |
0 |
- |
|
| AXGN |
Axogen Inc |
VP, Clinical&Translational Sc |
• – – |
2019-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
5,079 |
43,469 |
0 |
- |
|
| AXGN |
Axogen Inc |
VP, Clinical&Translational Sc |
• – – |
2019-12-18 |
4 |
D |
$16.73 |
$4,701 |
D/D |
(281) |
42,840 |
0 |
- |
|
| AXGN |
Axogen Inc |
VP, Clinical&Translational Sc |
• – – |
2019-12-18 |
4 |
A |
$0.00 |
$0 |
D/D |
1,150 |
43,121 |
0 |
- |
|
| AXGN |
Axogen Inc |
VP, Clinical&Translational Sc |
• – – |
2020-02-18 |
4 |
D |
$14.68 |
$27,143 |
D/D |
(1,849) |
48,526 |
0 |
- |
|
| AXGN |
Axogen Inc |
VP, Clinical&Translational Sc |
• – – |
2020-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
6,230 |
48,877 |
0 |
- |
|
| AXGN |
Axogen Inc |
VP, Clinical&Translational Sc |
• – – |
2020-04-28 |
4 |
OE |
$0.27 |
$683 |
D/D |
2,530 |
51,056 |
0 |
- |
|
| AXGN |
Axogen Inc |
VP, Clinical&Translational Sc |
• – – |
2020-12-15 |
4 |
D |
$16.50 |
$72,155 |
D/D |
(4,373) |
61,683 |
0 |
- |
|
| AXGN |
Axogen Inc |
VP, Clinical&Translational Sc |
• – – |
2020-12-15 |
4 |
OE |
$4.81 |
$72,150 |
D/D |
15,000 |
66,056 |
0 |
- |
|
| AXGN |
Axogen Inc |
VP, Clinical&Translational Sc |
• – – |
2020-12-18 |
4 |
A |
$0.00 |
$0 |
D/D |
575 |
62,258 |
0 |
- |
|
| AXGN |
Axogen Inc |
VP, Clinical&Translational Sc |
• – – |
2020-12-21 |
4 |
S |
$16.42 |
$2,414 |
D/D |
(147) |
62,111 |
0 |
% |
|
| AXGN |
Axogen Inc |
VP, Clinical&Translational Sc |
• – – |
2020-12-27 |
4 |
A |
$0.00 |
$0 |
D/D |
1,500 |
63,611 |
0 |
- |
|
| AXGN |
Axogen Inc |
VP, Clinical&Translational Sc |
• – – |
2020-12-29 |
4 |
S |
$17.81 |
$6,608 |
D/D |
(371) |
63,240 |
0 |
% |
|
| AXGN |
Axogen Inc |
VP, Clinical&Translational Sc |
• – – |
2021-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
6,231 |
68,404 |
0 |
- |
|
| AXGN |
Axogen Inc |
VP, Clinical&Translational Sc |
• – – |
2021-02-17 |
4 |
D |
$18.70 |
$34,857 |
D/D |
(1,864) |
68,082 |
0 |
- |
|
| AXGN |
Axogen Inc |
VP of Clin. & Trans. Sciences |
• – – |
2021-04-28 |
4 |
OE |
$2.86 |
$28,600 |
D/D |
10,000 |
78,082 |
0 |
- |
|
| AXGN |
Axogen Inc |
VP Peripheral Nerve Science |
• – – |
2021-07-19 |
4 |
A |
$0.00 |
$0 |
D/D |
1,580 |
80,818 |
0 |
- |
|
| AXGN |
Axogen Inc |
VP Peripheral Nerve Science |
• – – |
2021-07-20 |
4 |
D |
$19.20 |
$7,526 |
D/D |
(392) |
80,426 |
0 |
- |
|
| AXGN |
Axogen Inc |
VP Peripheral Nerve Science |
• – – |
2021-12-15 |
4 |
D |
$8.80 |
$36,705 |
D/D |
(4,171) |
86,255 |
0 |
- |
|
| AXGN |
Axogen Inc |
VP Peripheral Nerve Science |
• – – |
2021-12-15 |
4 |
OE |
$3.67 |
$36,700 |
D/D |
10,000 |
90,426 |
0 |
- |
|
| AXGN |
Axogen Inc |
VP Peripheral Nerve Science |
• – – |
2021-12-20 |
4 |
D |
$9.24 |
$1,331 |
D/D |
(144) |
86,686 |
0 |
- |
|
| AXGN |
Axogen Inc |
VP Peripheral Nerve Science |
• – – |
2021-12-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
575 |
86,830 |
0 |
- |
|
| AXGN |
Axogen Inc |
VP Peripheral Nerve Science |
• – – |
2021-12-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
750 |
87,436 |
0 |
- |
|
| AXGN |
Axogen Inc |
VP Peripheral Nerve Science |
• – – |
2021-12-27 |
4 |
D |
$9.74 |
$1,821 |
D/D |
(187) |
87,249 |
0 |
- |
|
42 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
